BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announces the launch of Derisq™, ...
BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announced that it will host ...
Dr. Gupta, Director, White House Office of National Drug Control Policy (2021-2025), to lead AI-powered drug discovery group. IRVINE, Calif., May 1, 2025 /PRNewswire/ -- GATC Health Corp, a leading ...
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA™ Circular RNA Therapeutics
HOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Circurna, (www.circurna.com) a biotechnology company advancing its proprietary ciRNA™ circular RNA platform, and GATC Health, a leading ...
Expanded alliance combines Lisata’s drug development expertise with GATC’s AI-powered Multiomics Advanced Technology ® platform to accelerate and improve success rates of next-generation drug ...
Lisata Therapeutics and GATC Health Corp have initiated a strategic partnership that aims to enhance the drug discovery and development process using GATC's advanced AI-powered Multiomics Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results